Alleviating Effect of Lafutidine on Toxicity of S-1: Adjuvant Chemotherapy of Gastric Cancer (AEOLUS).

Trial Profile

Alleviating Effect of Lafutidine on Toxicity of S-1: Adjuvant Chemotherapy of Gastric Cancer (AEOLUS).

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 12 May 2016

At a glance

  • Drugs Lafutidine (Primary) ; Gimeracil/oteracil/tegafur
  • Indications Gastric cancer
  • Focus Adverse reactions
  • Acronyms AEOLUS
  • Most Recent Events

    • 07 Jan 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
    • 02 Nov 2012 Actual initiation date changed from 1 Nov 2009 to 1 Jan 2010 as reported by University Hospital Medical Information Network - Japan.
    • 02 Nov 2012 Planned end date changed from 1 Dec 2012 to 1 Jan 2014 as reported by University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top